Welcome to our dedicated page for ITEM 9 LABS news (Ticker: INLB), a resource for investors and traders seeking the latest updates and insights on ITEM 9 LABS stock.
Item 9 Labs Corp. is a United States-based company specializing in the production of cannabis and cannabis-related products. They offer a wide range of products including flower, concentrates, distillates, and hardware. The company distributes medical cannabis strains, shatter, crumble, badder, thca, delta 8 thc, broad spectrum distillate, and live resin terpene sauce through licensed dispensaries in Arizona. Their headquarters are located in Phoenix, Arizona.
Item 9 Labs Corp. has retained Sharp Capital Advisors LLC to explore a potential sale of the Company. With two core operating businesses, Item 9 Labs and Unity Rd., the company has made significant strides in the cannabis industry. Item 9 Labs operates a highly efficient cultivation facility, while Unity Rd. is the first national cannabis dispensary franchisor. The Company also owns an additional asset in Pahrump, Nevada.
Unity Rd., the first national cannabis dispensary franchise, is set to exhibit at the 2023 Multi-Unit Franchising Conference from April 25-28, 2023 in Las Vegas. The franchise, launched in 2018, aims to connect with multi-unit entrepreneurs interested in the cannabis sector, which is projected to reach $48 billion in the next three years. Vice President Justin Livingston emphasizes the potential for success amid growing state legalizations of cannabis. Unity Rd. offers time-tested Standard Operating Procedures and extensive support for aspiring dispensary owners, aiming to simplify entry into this complex, rapidly expanding market. The company currently operates four shops and has signed agreements with over 20 entrepreneurial groups across more than 10 states.
Item 9 Labs Corp. (OTCQX: INLB) announced that CEO Mike Weinberger will participate in the Benzinga Cannabis Capital Conference in Miami on
Item 9 Labs Corp. (OTCQX: INLB) announced that CEO Mike Weinberger has been appointed to the National Cannabis Industry Association's Retail Committee for the 2023-2025 term. Since joining NCIA in February 2022, the company has expanded its reach in the cannabis market with the Unity Rd. franchise, which now operates four dispensaries in three states and has additional agreements for expansion across 10 states. This appointment aims to enhance advocacy for small cannabis businesses. Weinberger, who has over 20 years of experience in franchising, expressed pride in collaborating with NCIA to support the evolving cannabis landscape.
Item 9 Labs, an award-winning cannabis brand, reported a 30% increase in unit sales for February 2023 compared to the previous year, alongside improving profit margins. The company also celebrated a podium finish at the Spring Errl Cup in March 2023, securing third place in the “Sativa Flower” category for its Dosi Whoa strain. This performance reflects the brand's strengthening position in Arizona's cannabis market, which is among the top ten adult-use markets in the U.S. Executive Mike Weinberger expressed optimism about ongoing consumer demand amid upcoming cannabis events. Overall, Item 9 Labs continues to establish its presence and reputation in the industry.
Item 9 Labs Corp. (OTCQX: INLB) has signed an agreement to expand its cannabis dispensary franchise, Unity Rd., into Vermont, marking its first location in the state. This initiative aims to tap into Vermont's growing adult-use cannabis market, projected to generate $3 to $5 million by the end of 2023 and $120 to $145 million by 2026. Unity Rd. is providing support to a local entrepreneur in establishing the shop and navigating the licensing process. The Northeast region is expected to see increased consumer awareness and legalization, potentially benefiting the cannabis industry significantly.
Item 9 Labs Corp. announced the opening of a new Unity Rd. dispensary in the Glendale neighborhood of Denver, Colorado, marking its third location in the state. This new store will also serve as a flagship training center for franchisees. Construction has already commenced, with an expected opening this summer. The company’s social equity partner, Josh Davis, has secured the necessary licensing. Colorado's cannabis market is highly competitive, generating over $12.2 billion in adult-use sales since 2014, with Denver at its center. Unity Rd. aims to provide essential support and guidance to new dispensary operators.
FAQ
What is the current stock price of ITEM 9 LABS (INLB)?
What is the market cap of ITEM 9 LABS (INLB)?
What does Item 9 Labs Corp. specialize in?
Where is the headquarters of Item 9 Labs Corp. located?
What are some of the products offered by Item 9 Labs Corp.?
Who has Item 9 Labs Corp. retained to assist in a potential sale of the Company?
What are the two core operating businesses of Item 9 Labs Corp.?
How does Item 9 Labs Corp. distribute its products?
What additional asset does Item 9 Labs Corp. own?
When was Resolute Commercial Services appointed as the receiver for INLB?
What services does Sharp Capital Advisors LLC offer?